Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

New Leaf Ventures III, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/27/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A New Leaf Ventures III, L.P. reports a 9.8% stake in Harpoon Therapeutics, Inc.
02/11/2022 SC 13G New Leaf Ventures III, L.P. reports a 7.2% stake in Rallybio Corporation
02/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/11/2022 SC 13G/A New Leaf Ventures III, L.P. reports a 2.4% stake in Arvinas, Inc.
08/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/15/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/19/2019 4 New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 71,550 shares @ $36.0911, valued at $2.6M
Sold 69,292 shares @ $36.5433, valued at $2.5M
Sold 26,108 shares @ $37.0148, valued at $966.4k
Sold 78,450 shares @ $36.0911, valued at $2.8M
Sold 75,974 shares @ $36.5433, valued at $2.8M
Sold 28,626 shares @ $37.0148, valued at $1.1M
03/25/2019 SC 13D/A New Leaf Ventures III, L.P. reports a 2.2% stake in PDS Biotechnology Corporation
02/21/2019 SC 13G New Leaf Ventures III, L.P. reports a 12.2% stake in Harpoon Therapeutics, Inc.
02/14/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2019 SC 13G New Leaf Ventures III, L.P. reports a 6% stake in Unum Therapeutics Inc.
02/07/2019 3 New Leaf Ventures III, L.P. (10% Owner) has filed a Form 3 on Harpoon Therapeutics, Inc.
10/10/2018 SC 13G New Leaf Ventures III, L.P. reports a 7.1% stake in Arvinas, Inc.
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
07/03/2018 SC 13D New Leaf Ventures III, L.P. reports a 9.8% stake in APTINYX INC.
06/26/2018 4 New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 4 on Aptinyx Inc.
Txns: Converted 1,047,450 shares @ $0
Converted 1,197,076 shares @ $0
Converted 552,208 shares @ $0
Converted 243,345 shares @ $0
Bought 125,000 shares @ $16, valued at $2M
Bought 125,000 shares @ $16, valued at $2M
Converted 28,895,188 convertible preferred @ $0
Converted 33,022,786 convertible preferred @ $0
Converted 15,233,315 convertible preferred @ $0
Converted 6,712,986 convertible preferred @ $0
06/20/2018 3 New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Aptinyx Inc.
05/24/2018 3 New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc
10/11/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
09/28/2017 3 New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Deciphera Pharmaceuticals, Inc.
06/23/2016 3 Form 3 - Initial statement of beneficial ownership of securities
11/02/2015 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
10/13/2015 SC 13D New Leaf Ventures III, L.P. reports a 8.2% stake in Edge Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy